Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Venus Remedies Ltd.

Price on BSE   02 Apr,15:29 LIVE
908.00
+42.90
(+4.96%)

© 2026 Rediff.com
  • Volume :
  • 16,603.00
  • Prev Close :
  • 865.10
  • Day's H/L (Rs.) :
  • 908.35 - 844.00
  • 52wk H/L (Rs.) :
  • 950.00 - 285.80
  • Mkt Cap (Rs. Cr) :
  • 1,216.73
Price on NSE   02 Apr,15:57 LIVE
896.60
+35.55
(+4.13%)

© 2026 Rediff.com
  • Volume :
  • 94,776.00
  • Prev Close :
  • 861.05
  • Day's H/L (Rs.) :
  • 904.10 - 831.10
  • 52wk H/L (Rs.) :
  • 944.75 - 285.70
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Venus Remedies Ltd.
PE Ratios
23.10
EPS (Rs.)
39.30
Sales (Rs. Cr)
179.95
Face Value (Rs.)
10
Net Profit Margin(%)
8.21
Last Bonus
-
Last Dividend(%)
30
Return on Average Equity
8.91

News for Venus Remedies Ltd.

Venus Remedies: Drugs Approved in Vietnam
Venus Remedies secures marketing authorisations for Methotrexate, Cefuroxime, Irinotecan in Vietnam. Expands export footprint in South Asia.
Nov 09, 2025 12:22
Venus Remedies Renews Ukrainian GMP Certification
Venus Remedies has renewed its GMP certification from Ukraine's State Service on Medicines and Drugs Control (SMDC), reinforcing its position in the Ukrainian market and expanding its reach into...
May 24, 2025 10:37
Venus Remedies Gets Marketing Nod for Sugammadex in Philippines
Venus Remedies receives marketing authorisation for Sugammadex in the Philippines, marking a major step in its expansion into complex generics and the ASEAN market. Sugammadex is a relaxant-binding...
Mar 04, 2025 13:05
Venus Remedies Partners with UK Firm to Develop MET-X for Drug-Resistant Infections
Venus Remedies has partnered with Infex Therapeutics to develop MET-X, an innovative metallo-beta-lactamase inhibitor, to tackle drug-resistant gram-negative bacteria in India. The partnership aims...
Feb 25, 2025 12:18
Venus Remedies Secures Market Authorization for Anticoagulant in Indonesia
Venus Remedies has received marketing authorization from Indonesia for its Enoxaparin, an anticoagulant, in pre-filled syringes. The approval reinforces the company's presence in Southeast Asia and...
Feb 10, 2025 18:06

More News for Venus Remedies Ltd. »

News for Pharmaceuticals and health care

Pakistan Repays UAE Deposit: Debunks Social Media Claims
Pakistan rejects 'misleading' social media commentary on repaying USD 2 billion to UAE. Reaffirms strong bilateral ties and economic stability.
Apr 04, 2026 22:07
AI171 Crash: Families Seek Black Box Data Release
Families of Air India AI171 crash victims request PM Modi to release black box data. Seeking truth behind the tragedy.
Apr 04, 2026 21:23
Venu Srinivasan Resigns from Tata Trust
Venu Srinivasan resigns from Bai Hirabai Jamsetji Tata Navsari Charitable Institution. Follows challenge from Mehli Mistry.
Apr 04, 2026 20:49
Pawan Hans Crash: Flotation System Not Activated
AAIB report reveals emergency flotation system wasn't activated during Pawan Hans helicopter crash near Mayabunder. One fatality reported.
Apr 04, 2026 19:36
Pharma: Reduce Import Dependence, Diversify Exports
Commerce Secy urges pharma industry to cut import reliance, diversify exports for resilience amid global uncertainties.
Apr 04, 2026 18:24

More News »

Top News

Iran War: US Gas Prices & Transport Costs Surge
Iran war impacts US: Gas prices surge, airlines hike fees, and Amazon adds fuel surcharge. Supply chain disruptions loom.
Apr 05, 2026 08:36
West Asia Crisis: Impact on J-K Industry Reviewed
J-K Industry Dept reviews West Asia crisis impact. Seeks stakeholder input, addresses energy, transportation, MSME payments.
Apr 04, 2026 23:54
Pakistan Repays UAE Deposit: Debunks Social Media Claims
Pakistan rejects 'misleading' social media commentary on repaying USD 2 billion to UAE. Reaffirms strong bilateral ties and economic stability.
Apr 04, 2026 22:07
AI171 Crash: Families Seek Black Box Data Release
Families of Air India AI171 crash victims request PM Modi to release black box data. Seeking truth behind the tragedy.
Apr 04, 2026 21:23
Venu Srinivasan Resigns from Tata Trust
Venu Srinivasan resigns from Bai Hirabai Jamsetji Tata Navsari Charitable Institution. Follows challenge from Mehli Mistry.
Apr 04, 2026 20:49

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com